Activity value 72International Buyer&Supplier,Last transaction date:
2026-01-08
Overview
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for bcn pharma s.a. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 2 transactions, with a transaction quantity of 98 and a transaction weight of 878.
YearTransactionsQuantityWeight
2025740622417.4
2026298878
Bill of lading data
<
1/15
>
Trade date
2026/01/08
B/L No.
2026010553082
Suppliers
shanghai flower medical equipment co.ltd.
Buyers
bcn pharma s.a.
POLs
——
PODs
mercure logistics corp,
Supply area
China
Purchas area
Panama
Weight
401.68kg
Amount
1092
Hs code
901890900000
Product tags
medical supplies
Product description
SOPORTE DE INFUSION
Expand
Trade date
2026/01/08
B/L No.
2026010553082
Suppliers
shanghai flower medical equipment co.ltd.
Buyers
bcn pharma s.a.
bcn pharma s.a. is International Buyer&Supplier,
and primarily engages in the import and export business of products such as hospital bed,metal rack,medical supplies.
According to the 52wmb.com global trade database, as of 2026-01-08, the company has completed 70 international trades,
with its main trading regions covering costa rica,china,india etc.
The core products include HS940290120000,HS392690990090,HS901890900000 etc,
often transported via panama city,port zona libre de colon, port cocosolito etc,
and its main trading partners are paramount surgimed ltd.,shanghai flower medical equipment co.ltd.,hubei yinkang medical equipment so.ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on bcn pharma s.a. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.